Influential ISCHEMIA Trial Does Not Reflect Majority of SIHD Patients, According to New Large-Scale Registry
The population represented in the ISCHEMIA trial for stable ischemic heart disease (SIHD) – which commonly informs contemporary decision-making – does not appear to reflect the majority of patients encountered by U.S. coronary interventionalists today, according to a large, new registry study.